Who owns NEUROSENSE THERAPEUTICS LTD?
- Ticker: NRSN
- CUSIP Number: m74240108
Tip: Access positions for across all investors
Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurosense Therapeutics stock
Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Squarepoint Ops | 95k | $119k | 91% | Sep 2025 |
|
| Morgan Stanley | 80k | $151k | 100% | Jun 2025 |
|
| Meitav Dash Investments | 40k | $50k | 0% | Sep 2025 |
|
| Two Sigma Investments | 21k | $26k | 100% | Sep 2025 |
|
| Commonwealth Equity Services | 21k | $26k | 0% | Sep 2025 |
|
| Geode Capital Management | 16k | $20k | 0% | Sep 2025 |
|
| UBS Group | 15k | $18k | 810% | Sep 2025 |
|
| SBI Securities | 1.5k | $1.8k | -67% | Sep 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $1.2k | -91% | Sep 2025 |
|
| CWM | 1.0k | $1.0k | 0% | Sep 2025 |
|
Who sold out of Neurosense Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 149k | $282k |
| Yorkville Advisors Global | Jun 2025 | 60k | $113k |
| Jane Street | Jun 2025 | 29k | $54k |
| Hrt Financial | Jun 2025 | 22k | $41k |
| Marshall Wace | Jun 2025 | 12k | $22k |
| Bnp Paribas Arbitrage, Snc | Jun 2025 | 6.8k | $13k |
| Hurley Capital | Jun 2025 | 6.5k | $12k |